tiprankstipranks
Sprint Bioscience AB (DE:5JA1)
FRANKFURT:5JA1
Germany Market
5JA1
Sprint Bioscience AB
RESEARCH TOOLSreports

Sprint Bioscience AB (5JA1) Income Statement

0 Followers

Sprint Bioscience AB Income Statement

Last quarter (Q4 2025), Sprint Bioscience AB's total revenue was kr133.91M, an increase of 723.19% from the same quarter last year. In Q4, Sprint Bioscience AB's net income was kr113.17M. See Sprint Bioscience AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 167.17Mkr 65.64Mkr 50.48Mkr 83.00Kkr 35.11M
Gross Profit
kr 97.33Mkr 37.30Mkr 41.79Mkr -60.91Mkr 24.68M
Operating Expenses
kr 0.00kr 56.97Mkr 42.63Mkr 47.32Mkr 50.14M
Depreciation and Amortization
kr 1.07Mkr 958.00Kkr 447.00Kkr 618.00Kkr 590.00K
EBITDA
kr 98.40Mkr -17.32Mkr 396.00Kkr -60.00Mkr -24.49M
Operating Income
kr 97.33Mkr -19.67Mkr -845.00Kkr -60.91Mkr -25.47M
Other Income/Expenses
kr -5.59Mkr 1.39Mkr 407.00Kkr 739.00Kkr 383.00K
Pretax Income
kr 91.74Mkr -18.28Mkr -438.00Kkr -60.17Mkr -25.08M
Net Income
kr 91.74Mkr -18.28Mkr -438.00Kkr -60.17Mkr -25.35M
Per Share Metrics
Basic EPS
kr 0.99kr -0.26kr -0.01kr -1.43kr -0.73
Diluted EPS
kr 0.99kr -0.26kr -0.01kr -1.43kr -0.73
Weighted Average Shares Outstanding
 92.61M 69.82M 69.81M 42.06M 34.65M
Weighted Average Shares Outstanding (Diluted)
 92.61M 69.82M 69.81M 42.06M 34.65M
Currency in SEK

Sprint Bioscience AB Earnings and Revenue History